Atlas Trials

Belinostat and Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Aggressive B-Cell NHL

Clinical trial NCT01686165 · COMPLETED

Trial details

NCT number
NCT01686165
Sponsor
University of Arizona
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Anaplastic Large Cell LymphomaRecurrent Adult Diffuse Large Cell LymphomaRecurrent Mantle Cell Lymphoma
Start date
2012-08-31
Primary completion
2016-02-09
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.